LACHOWICZ, JOANNA IZABELA
 Distribuzione geografica
Continente #
EU - Europa 151.754
NA - Nord America 6.811
AS - Asia 2.643
SA - Sud America 450
AF - Africa 59
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 161.734
Nazione #
IT - Italia 149.091
US - Stati Uniti d'America 6.694
NL - Olanda 1.074
SG - Singapore 1.024
CN - Cina 980
SE - Svezia 544
BR - Brasile 377
UA - Ucraina 357
VN - Vietnam 178
DE - Germania 172
GB - Regno Unito 162
FI - Finlandia 128
CA - Canada 79
KR - Corea 78
SA - Arabia Saudita 57
IN - India 55
FR - Francia 49
HK - Hong Kong 38
JP - Giappone 33
ES - Italia 30
MX - Messico 28
TR - Turchia 27
AR - Argentina 26
IR - Iran 25
BD - Bangladesh 24
RU - Federazione Russa 24
IQ - Iraq 22
AT - Austria 19
PL - Polonia 19
ID - Indonesia 17
IE - Irlanda 17
PK - Pakistan 16
ZA - Sudafrica 16
EC - Ecuador 15
BE - Belgio 14
AU - Australia 12
MA - Marocco 12
UZ - Uzbekistan 11
EG - Egitto 10
RO - Romania 10
GR - Grecia 9
LT - Lituania 9
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
CO - Colombia 6
IL - Israele 6
TH - Thailandia 6
UY - Uruguay 6
CL - Cile 5
CZ - Repubblica Ceca 5
PA - Panama 5
TN - Tunisia 5
VE - Venezuela 5
JO - Giordania 4
KE - Kenya 4
PE - Perù 4
PY - Paraguay 4
TW - Taiwan 4
AZ - Azerbaigian 3
DK - Danimarca 3
DZ - Algeria 3
PH - Filippine 3
PS - Palestinian Territory 3
QA - Qatar 3
AM - Armenia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
EU - Europa 2
HU - Ungheria 2
KW - Kuwait 2
MN - Mongolia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CD - Congo 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 161.729
Città #
Cagliari 146.115
Uta 2.475
Amsterdam 1.057
Ashburn 935
Fairfield 708
Woodbridge 489
Dallas 445
Singapore 414
Nyköping 367
Chandler 334
Houston 311
Boardman 298
Wilmington 269
Seattle 265
Ann Arbor 254
Cambridge 230
Beijing 197
Jacksonville 180
Dearborn 164
Los Angeles 123
Santa Clara 115
New York 99
Boston 78
Shanghai 71
Nanjing 70
Hefei 69
Helsinki 66
Seoul 66
Dong Ket 60
Ho Chi Minh City 60
Escalaplano 58
San Diego 52
Redwood City 48
Buffalo 47
The Dalles 44
London 38
Guangzhou 35
Sassari 34
Chicago 33
Hong Kong 33
São Paulo 31
Hangzhou 29
Nanchang 29
Hanoi 25
Mountain View 25
Tianjin 25
Redondo Beach 23
Rome 23
Shenyang 22
Atlanta 21
Milan 21
Nuremberg 21
Tokyo 21
Toronto 21
Munich 19
Brooklyn 18
Phoenix 18
Changsha 17
Montreal 17
Ottawa 16
Hebei 15
Orem 15
Norwalk 14
Jiaxing 13
Warsaw 13
Dublin 12
Jinan 12
Orange 12
Rio de Janeiro 12
Turku 12
Vienna 12
Brasília 11
Brussels 11
Frankfurt am Main 11
Pune 11
Zhengzhou 11
Johannesburg 9
Stockholm 9
Tashkent 9
Belo Horizonte 8
Da Nang 8
Falls Church 8
Mumbai 8
Salt Lake City 8
Ankara 7
Baghdad 7
Council Bluffs 7
Kilburn 7
Mexico City 7
Poplar 7
Salvador 7
Shenzhen 7
Spin 7
Washington 7
Wuhan 7
Auburn Hills 6
Calcinelli 6
Campinas 6
Chennai 6
Columbus 6
Totale 157.619
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.703
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.810
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.596
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.516
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.484
Multi analytical technique study of human bones from an archaeological discovery 3.407
Multiple Sclerosis and environmental factors. 3.253
Adsorption of Cu2+ and Zn2+ on SBA-15 mesoporous silica functionalized with triethylenetetramine chelating agent 3.216
Gold - Old drug with new potentials 3.178
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.905
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.754
Metal coordination of thymosin β4: Chemistry and possible implications 2.748
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.716
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.622
Thymosin b4 cytoplasmic/nuclear translocation as a new marker of cellular stress. A Caco2 case study 2.560
Looking at new ligands for chelation therapy 2.513
null 2.477
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.458
Depleted uranium and human health 2.422
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.398
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.376
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.263
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.204
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.199
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.178
Do anti-diabetic drugs act as copper ligands? 2.166
Toxicity of nanoparticles: etiology and mechanisms 2.132
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.034
Tungsten or wolfram: Friend or foe? 2.023
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.012
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.947
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.937
Kill or cure: Misuse of chelation therapy for human diseases 1.901
The meaning of aluminium exposure on human health and aluminium-related diseases 1.889
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.863
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.857
Silver coordination compounds: A new horizon in medicine 1.836
Alarming use of chelation therapy 1.824
Chemical features of in use and in progress chelators for iron overload 1.807
Improving Metal Adsorption on Triethylenetetramine (TETA) Functionalized SBA-15 Mesoporous Silica Using Potentiometry, EPR and ssNMR 1.804
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.803
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.794
The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides 1.775
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.772
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.769
State of art in chelating agents for the clinical treatment of metal poisoning 1.769
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.763
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.750
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.732
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.730
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.724
Noble metals in medicine: Latest advances 1.714
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.687
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.679
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.589
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.585
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.521
Toxicity of nanoparticles 1.367
Living with the enemy: from protein-misfolding pathologies we know, to those we want to know 1.203
null 1.188
Warns against unapproved ‘chelation therapy’ 1.168
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.124
Zinc as a drug for Wilson’s disease, non-alcoholic liver disease and covid-19-related liver injury 1.074
Grafting of the 2,8-dithia-5-aza-2,6-pyridinophane macrocycle on SBA-15 mesoporous silica for the removal of Cu2+ and Cd2+ ions from aqueous solutions: synthesis, adsorption, and complex stability studies 1.000
null 941
Undercover Toxic Ménage à Trois of Amylin, Copper (II) and Metformin in Human Embryonic Kidney Cells 922
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 915
Nutritional iron deficiency: the role of oral iron supplementation 905
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 887
Kojic acid derivatives as double face ligands for metal and phosphate ions. 873
Kojic Acid Derivatives as Iron (III) and Aluminium (III) Chelators 868
Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis 862
null 845
Exploring cell surface markers and cell-cell interactions of human breast milk stem cells 820
Manganese and cobalt binding in a multi-histidinic fragment 812
Metal complex formation and anticancer activity of cu(I) and cu(ii) complexes with metformin 810
Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexes 809
Metals and metal-nanoparticles in human pathologies: From exposure to therapy 773
Kojic Acid derivate as a selective inhibitor of mitosis in colorectal and glioblastoma cancer cells 740
Nickel Binding Sites in Histone Proteins: Spectroscopic and Structural Characterization 712
Fluorescent squaramide ligands for cellular imaging and their encapsulation in cubosomes 703
Potentiometric, spectrophotometric and computer studies with aspergillic acid and its derivatives 679
Generalized scleroderma-like induration associated with D-penicillamine elastosis perforans serpiginosa in Wilson's disease 627
Interaction between aspergillic acid and iron(III). A potentiometric, UV-Vis, 1H-NMR and quantum chemical study 539
Cell starvation increases uptake of extracellular Thymosin β4 and its complexes with calcium 515
Toward the renal vesicle: Ultrastructural investigation of the cap mesenchyme splitting process in the developing kidney 498
Effect of substituents on complex stability aimed at designing new iron(III) and aluminum(III) chelators 487
NMR as a “gold standard” method in drug design and discovery 483
Cooking Particulate Matter: A Systematic Review on Nanoparticle Exposure in the Indoor Cooking Environment 478
Human breast milk cells are positive for the pioneer transcription factor ISL1 478
Nuovi derivati dell’acido kojico come chelanti per il ferro(III). 466
What doesn't kill you makes you stronger: Future applications of amyloid aggregates in biomedicine 448
A pilot study of occupational exposure to ultrafine particles during 3D printing in research laboratories 360
You are what you eat: Application of Metabolomics Approaches to Advance Nutrition Research 347
In silico design of mimosine containing peptides as new efficient chelators of aluminum 338
The interaction of aluminum with catecholamine-based neurotransmitters: Can the formation of these species be considered a potential risk factor for neurodegenerative diseases? 332
Towards the functional high-resolution coordination chemistry of blood plasma human serum albumin 328
Fluxomics - New Metabolomics Approaches to Monitor Metabolic Pathways 264
Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations 245
Therapeutic Properties of Vanadium Complexes 190
Totale 161.567
Categoria #
all - tutte 202.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116.019 0 0 0 0 0 4.253 2.833 2.381 1.022 2.220 1.995 1.315
2021/20227.745 972 731 398 535 609 618 475 271 544 755 913 924
2022/202310.333 794 1.170 1.265 886 852 1.178 597 948 686 632 785 540
2023/202411.762 588 468 435 622 1.149 1.846 1.925 1.130 521 796 1.088 1.194
2024/202524.614 5.936 6.383 3.084 2.268 1.316 1.548 1.680 155 337 1.264 312 331
2025/20263.076 498 353 799 529 438 459 0 0 0 0 0 0
Totale 162.152